Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

Journal of Clinical Investigation

Volumn 109, Issue 12, 2002, Pages 1551-1559

  Muraoka, Rebecca S ^a,b   Dumont, Nancy ^a   Ritter, Christoph A ^c   Dugger, Teresa C ^c   Brantley, Dana M ^c   Chen, Jin ^b,c   Easterly, Evangeline ^a   Renee Roebuck, L ^c   Ryan, Sarah ^d   Gotwals, Philip J ^d   Koteliansky, Victor ^d   Arteaga, Carlos L ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FC RECEPTOR; FC RECEPTOR TRANSFORMING GROWTH FACTOR BETA2 RECEPTOR FUSION PROTEIN; PROTEIN FLHRL1; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR ANTAGONIST; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BREAST CARCINOMA; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; LUNG METASTASIS; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN INTERACTION;

EID: 0036086409     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215234     Document Type: Article

References (38)

1. The hallmarks of cancer
2. TGF-beta signal transduction
3. TGF-beta signaling in tumor suppression and cancer progression
4. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1
5. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation
6. Mammary tumor suppression by transforming growth factor beta 1 transgene expression
7. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
8. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of eplthelial tumor cells
9. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
10. Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta
11. Integrin alphalbetal and transforming growth factor-betal play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy
12. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type 11 receptor: A potential new therapy for hepatic fibrosis
13. Induction of mammary tumors by expression of Polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
14. Dynamic expression and activity of NF-kappaB during post-natal mammary gland morphogenesis
15. Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by Polyomavirus middle T antigen
16. Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function
17. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways
18. Transforming growth factor-beta receptors on human endometrial cells: Identification of the type I, II, and III receptors and glycosyl-phosphatidylinositol anchored TGF-beta binding proteins
19. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration
20. A critical step in metastasis: In vivo analysis of in travasation at the primary rumor
21. Noninvasive visualization of tumors in rodent dorsal skin window chambers
22. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
23. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response co the carcinogen 7,12-dimethylbenz-[a]-anthracene
24. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice
25. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice
26. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in Polyomavirus middle T-mediated mammary tumorigenesis
27. Cellular survival: A play in three Akts
28. Akt promotes cell survival by phospborylating and inhibiting a Forkhead transcription factor
29. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN
30. Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1
31. Invasion and metastasis of a mammary tumor involves TGF-beta signaling
32. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
33. TGF-beta induced transdifferenriation of mammary epithelial cells to mesenchymal cells: Involvement of type 1 receptors
34. Inactivation of the type TGF-beta receptor in colon cancer cells with microsatelite instability
35. Microsatellite, instability in cancer of the proximal colon
36. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells
37. PDGF,TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate
38. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal